Durvalumab in Combination with Chemoradiotherapy in Patients with Head and Neck Squamous Cell Carcinoma: Results from the Phase 1 CLOVER Study.
Head & Neck(2024)
Key words
chemoradiotherapy,CLOVER,durvalumab,HNSCC,Phase 1
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined